一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Extracellular Vesicles >>article
Journal of Extracellular Vesicles

Journal of Extracellular Vesicles

IF: 15.5
Download PDF

Targeted Blockage of Pathological Extracellular Vesicles and Particles From Fibroblast-Like Synoviocytes for Osteoarthritis Relief: Proteomic Analysis and Cellular Effect

Published:8 September 2025 DOI: 10.1002/jev2.70162
Bin Liu, Yansi Xian, Tao Shen, Yu Ben, Wenshu Wu, Yong Shi, Xueying An, Rui Peng, Wentian Gao, Wang Gong, Xiang Chen, Baosheng Guo, Qing Jiang

Abstract

Osteoarthritis (OA), the prevalent debilitating joint disorder, is accelerated by dysregulated intercellular crosstalk, yet the role of fibroblast-like synoviocyte (FLS)-derived extracellular vesicles and particles (EVPs) in disease progression remains to be elucidated. Here, integrative analysis of clinical specimens, animal models, and publicly available datasets revealed significant alterations in exosomal pathways within OA synovium. Proteomic profiling revealed distinct molecular signatures in EVPs derived from inflammatory and senescent FLSs, reflecting the pathophysiological status of their parent cells. We demonstrated that FLSs under inflammatory and senescent states in OA secreted pathogenic EVPs that propagated joint degeneration by disrupting chondrocyte homeostasis, polarizing macrophages towards a pro-inflammatory phenotype, and impairing chondrogenesis of mesenchymal stem cells. To therapeutically target these pathogenic EVPs, we engineered an adeno-associated virus 9 (AAV9) vector fused with a synovium-affinity peptide (HAP-1) to deliver shRNA against Rab27a, a key regulator of EVP secretion. Intra-articular administration of the engineered AAV9 in a murine OA model induced by destabilization of the medical meniscus significantly reduced synovial hyperplasia, cartilage degradation and inflammatory responses, while demonstrating satisfactory systemic biosafety. Our findings establish FLS-derived EVPs as critical mediators of OA pathogenesis and propose a targeted strategy to block their secretion, offering a promising disease-modifying therapeutic avenue for OA.

Substances (6)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Bleomycin sulfate 9041-93-4 C110H168N34O46S7 562 suppliers $28.00-$4891.00
Bleomycin sulfate 9041-93-4 C110H168N34O46S7 562 suppliers $28.00-$4891.00
Bleomycin sulfate 9041-93-4 C110H168N34O46S7 562 suppliers $28.00-$4891.00
Bleomycin sulfate 9041-93-4 C110H168N34O46S7 562 suppliers $28.00-$4891.00
Bleomycin sulfate - mixture of Bleomycin A2, B2 9041-93-4 - Inquiry
Bleomycin sulfate - mixture of Bleomycin A2, B2 9041-93-4 - Inquiry

Similar articles

永吉县| 古丈县| 崇左市| 临朐县| 简阳市| 兴安县| 漯河市| 兰坪| 安达市| 石楼县| 铁力市| 德保县| 阜新市| 玉山县| 呈贡县| 珠海市| 盐津县| 安宁市| 志丹县| 桐城市| 隆回县| 石棉县| 宜州市| 正安县| 和田市| 宣化县| 潞城市| 常山县| 马鞍山市| 陇川县| 乐清市| 虹口区| 台南市| 丘北县| 民权县| 和顺县| 福海县| 海口市| 乐亭县| 阳西县| 安岳县|